Debbie Wasserman Schultz actually said...

This committee's investigation shines a spotlight on the ways that drug companies use litigation as a key part of their strategic plans to delay generic entry.

Context

Wasserman Schultz discusses drug companies' tactics to maintain high prices through litigation.

09/30/2020

https://congress.gov...

More Debbie Wasserman Schultz Quotes

View All Debbie Wasserman Schultz Quotes